Biotech

Israeli mathematician uses AI to decode human immune system

How an Israeli mathematician is using AI to decode the human immune system and transform patient treatment

Noam Solomon, CEO of Immunai, is using AI technology to map a key part of the human physiology – the immune system – and help discover and develop therapeutics that will ultimately save lives.
Visitors walk across salt formations along the receding shoreline of the Dead Sea, a stark sign of the region’s growing environmental crisis.

Israel's overlooked challenge: Environmental damage from two years of war - from the editor

 CEO and co-founder of Immunai Noam Solomon.

Immunai, Bristol Myers Squibb sign AI immune-data collaboration

WORKERS TAKE care of cannabis plants at a farm in central Israel,  late last year.

Israeli researchers develop SafeWax coating that could cut pesticide use by 50%


How do you make it to the top? Three female leaders give their best advice

What are three mottos you should swear by, according to three of the biggest biotechnological leaders in Israel?

  From left: Regine Shevach, head of Merck's Israel Technologies Center; Prof. Rivka Carmi, former president of Ben-Gurion University; Galia Inbar, executive vice president and chief human resources officer and head of global communications and brand at Teva

CRISPR gene editing may cause permanent damage - study

Caution from researchers at Tel Aviv University: CRISPR gene editing can damage the genome and might trigger cancer.

 Chromosome segregation In dividing cells. Cell cytoskeleton is depicted in red, DNA is depicted in blue and a protein that marks dividing cells is depicted in green.

Precise Bio partners with ZEISS to develop bio-printed cornea implants

These bio-printed eye tissues would be used for transplants to treat vision correction and corneal diseases such as keratoconus.

 Precise Bio's bio-fabricated cornea

BioGenCell raises $16m. for chronic disease treatment

The company’s treatment has already prevented loss of limb in several patients during Phase I trials.

 Microglia (green) that were “matured” in the lab from stem cells of ALS patients; the cells’ nuclei are in blue. Viewed with confocal microscopy

AI bio-tech company Nucleai raises $33M, brings in new executives

Nuclei aims to use the funds to further its efforts to transform drug development and clinical treatments.

 Nucleai's team

Israeli Biotech company says it can revolutionize drug development

Tissue Dynamics Ltd., an Israeli biotechnology company, says it can cut drug development cost by 40% to 80% and the time required by 30% to 50%.

 Best Weight Loss Pills

‘Cell-based, innovative products for a better future’

Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials

 IN COLLABORATION with the Tnuva Group, Pluristem will develop raw material for the cultured meat market.

Reimagining the future of food

Israel’s northern Galilee has become the new go-to destination for food-tech start-ups

 Planteam’s plant protein made without fillers, binders, mediators, gluten, additives, preservatives, or GMO

3D bioprinting tech to be licensed by Tel Aviv University

The technology was used to print a heart made of human cells and extracellular matrix at TAU in 2019.

A 3D printed, small-scaled human heart engineered from the patient’s own materials and cells.

New method for mapping gene expression could be used alongside cancer therapy - study

Findings by Israeli scientists may completely change the way we approach observing the biological processes of the human body in the future.  

 Bar-Shir team - Dr. Amnon Bar-Shir and Dr. Hyla Allouche-Arnon